Increased Diameters of the Internal Cerebral Veins and the Basal Veins of Rosenthal Are Associated with White Matter Hyperintensity Volume

References

1. 1.↵
   2. Pantoni L,
   3. Garcia JH,
   4. Gutierrez JA

   . Cerebral white matter is highly vulnerable to ischemia. Stroke 1996;27:1641–47 doi:10.1161/01.str.27.9.1641 pmid:8784142

   Abstract/FREE Full Text
2. 2.↵
   2. Prins ND,
   3. Scheltens P

   . White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 2015;11:157 doi:10.1038/nrneurol.2015.10

   CrossRefPubMed
3. 3.↵
   2. Brickman AM,
   3. Provenzano FA,
   4. Muraskin J, et al

   . Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol 2012;69:1621–27 doi:10.1001/archneurol.2012.1527 pmid:22945686

   CrossRefPubMed
4. 4.↵
   2. Lo RY,
   3. Jagust WJ

   ; Alzheimer's Disease Neuroimaging Initiative. Vascular burden and Alzheimer disease pathologic progression. Neurology 2012;79:1349–55 doi:10.1212/WNL.0b013e31826c1b9d pmid:22972646

   Abstract/FREE Full Text
5. 5.↵
   2. Brickman AM,
   3. Schupf N,
   4. Manly JJ, et al

   . APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role? Alzheimers Dement 2014;10:619–29 doi:10.1016/j.jalz.2014.07.155 pmid:25304991

   CrossRefPubMed
6. 6.↵
   2. Lee S,
   3. Viqar F,
   4. Zimmerman ME, et al

   . White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol 2016;79:929–39 doi:10.1002/ana.24647 pmid:27016429

   CrossRefPubMed
7. 7.↵
   2. Ahn KH,
   3. Lyoo IK,
   4. Lee HK, et al

   . White matter hyperintensities in subjects with bipolar disorder. Psychiatry Clin Neurosci 2004;58:516–21 doi:10.1111/j.1440-1819.2004.01294.x pmid:15482583

   CrossRefPubMed
8. 8.↵
   2. Kuller LH,
   3. Longstreth W Jr.,
   4. Arnold AM, et al

   . White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004;35:1821–25 doi:10.1161/01.STR.0000132193.35955.69 pmid:15178824

   Abstract/FREE Full Text
9. 9.↵
   2. Snyder HM,
   3. Corriveau RA,
   4. Craft S, et al

   . Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimers Dement 2015;11:710–17 doi:10.1016/j.jalz.2014.10.008 pmid:25510382

   CrossRefPubMed
10. 10.↵
    2. Moody DM,
    3. Brown WR,
    4. Challa VR, et al

    . Periventricular venous collagenosis: association with leukoaraiosis. Radiology 1995;194:469–76 doi:10.1148/radiology.194.2.7824728 pmid:7824728

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Black S,
    3. Gao F,
    4. Bilbao J

    . Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke 2009;40:S48–52 doi:10.1161/STROKEAHA.108.537704 pmid:19064767

    Abstract/FREE Full Text
12. 12.↵
    2. Keith J,
    3. Gao F-Q,
    4. Noor R, et al

    . Collagenosis of the deep medullary veins: an underrecognized pathologic correlate of white matter hyperintensities and periventricular infarction? J Neuropathol Exp Neurol 2017;76:299–312 doi:10.1093/jnen/nlx009 pmid:28431180

    CrossRefPubMed
13. 13.↵
    2. Moody DM,
    3. Brown WR,
    4. Challa VR, et al

    . Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann NY Acad Sci 1997;826:103–16 doi:10.1111/j.1749-6632.1997.tb48464.x pmid:9329684

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Mittal S,
    3. Wu Z,
    4. Neelavalli J, et al

    . Susceptibility-weighted imaging: technical aspects and clinical applications, Part 2. AJNR Am J Neuroradiol 2009;30:232–52 doi:10.3174/ajnr.A1461 pmid:19131406

    Abstract/FREE Full Text
15. 15.↵
    2. Brickman AM,
    3. Schupf N,
    4. Manly JJ, et al

    . Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol 2008;65:1053–61 doi:10.1001/archneur.65.8.1053 pmid:18695055

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Luchsinger J,
    3. Reitz C,
    4. Honig LS, et al

    . Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005;65:545–51 doi:10.1212/01.wnl.0000172914.08967.dc pmid:16116114

    Abstract/FREE Full Text
17. 17.↵
    2. Piriz A,
    3. Reyes D,
    4. Narkhede A, et al

    . Cerebrovascular disease and neurodegeneration in Alzheimer's disease with and without a strong family history: a pilot magnetic resonance imaging study in Dominican Republic. J Alzheimers Dis 2018;66:1519–28 doi:10.3233/JAD-180807 pmid:30412503

    CrossRefPubMed
18. 18.↵
    2. Brickman AM,
    3. Muraskin J,
    4. Zimmerman ME

    . Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci 2009;11:181–90 pmid:19585953

    PubMed
19. 19.↵
    2. Brickman AM,
    3. Sneed JR,
    4. Provenzano FA, et al

    . Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res 2011;193:101–06 doi:10.1016/j.pscychresns.2011.03.007 pmid:21680159

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Fedorov A,
    3. Beichel R,
    4. Kalpathy-Cramer J, et al

    . 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 2012;30:1323–41 doi:10.1016/j.mri.2012.05.001 pmid:22770690

    CrossRefPubMedWeb of Science
21. 21.↵
    2. McGraw KO,
    3. Wong SP

    . Forming inferences about some intraclass correlation coefficients. Psychological Methods 1996;1:30 doi:10.1037/1082-989X.1.1.30

    CrossRefWeb of Science
22. 22.↵
    2. Koo TK,
    3. Li MY

    . A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15:155–63 doi:10.1016/j.jcm.2016.02.012 pmid:27330520

    CrossRefPubMed
23. 23.↵
    2. Brickman AM,
    3. Zahodne LB,
    4. Guzman VA, et al

    . Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence. Neurobiol Aging 2015;36:27–32 doi:10.1016/j.neurobiolaging.2014.07.019 pmid:25155654

    CrossRefPubMed
24. 24.↵
    2. Gao F,
    3. van Gaal S,
    4. Levy-Cooperman N, et al

    . P2-010: does variable progression of incidental white matter hyperintensities in Alzheimer's disease relate to venous insufficiency? Alzheimer's & Dementia 2008;4:T368–T9 doi:10.1016/j.jalz.2008.05.1090 pmid:25071553

    CrossRefPubMed
25. 25.↵
    2. Yan S,
    3. Wan J,
    4. Zhang X, et al

    . Increased visibility of deep medullary veins in leukoaraiosis: a 3-T MRI study. Front Aging Neurosci 2014;6:144 doi:10.3389/fnagi.2014.00144 pmid:25071553

    CrossRefPubMed
26. 26.↵
    2. Zhang R,
    3. Zhou Y,
    4. Yan S, et al

    . A brain region-based deep medullary veins visual score on susceptibility weighted imaging. Front Aging Neurosci 2017;9:269 doi:10.3389/fnagi.2017.00269 pmid:28848426

    CrossRefPubMed
27. 27.↵
    2. Thore CR,
    3. Anstrom JA,
    4. Moody DM, et al

    . Morphometric analysis of arteriolar tortuosity in human cerebral white matter of preterm, young, and aged subjects. J Neuropathol Exp Neurol 2007;66:337–45 doi:10.1097/nen.0b013e3180537147 pmid:17483690

    CrossRefPubMed
28. 28.↵
    2. Pettersen JA,
    3. Keith J,
    4. Gao F, et al

    . CADASIL accelerated by acute hypotension arterial and venous contribution to leukoaraiosis. Neurology 2017;88:1077–80 doi:10.1212/WNL.0000000000003717 pmid:28202707

    Abstract/FREE Full Text
29. 29.↵
    2. Makedonov I,
    3. Black SE,
    4. MacIntosh BJ

    . BOLD fMRI in the white matter as a marker of aging and small vessel disease. PLoS One 2013;8:e67652 doi:10.1371/journal.pone.0067652 pmid:23844047

    CrossRefPubMed
30. 30.↵
    2. Bousser M,
    3. Chiras J,
    4. Bories J, et al

    . Cerebral venous thrombosis–a review of 38 cases. Stroke 1985;16:199–13 doi:10.1161/01.str.16.2.199 pmid:3975957

    Abstract/FREE Full Text
31. 31.↵
    2. Krayenbühl HA

    . Cerebral venous and sinus thrombosis. Neurol Med Chir (Tokyo) 1968;10:1–24 doi:10.2176/nmc.10.1 pmid:4194573

    CrossRefPubMed
32. 32.↵
    2. Leach JL,
    3. Fortuna RB,
    4. Jones BV, et al

    . Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 2006;26:S19–41 doi:10.1148/rg.26si055174 pmid:17050515

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Boldrey E,
    3. Miller ER

    . Arteriovenous fistula (aneurysm) of the great cerebral vein (of Galen) and the circle of Willis: report on two patients treated by ligation. Arch Neurol Psychiatry 1949;62:778–83 doi:10.1001/archneurpsyc.1949.02310180079009 pmid:15396364

    CrossRefPubMed
34. 34.↵
    2. Doubal FN,
    3. MacLullich AM,
    4. Ferguson KJ, et al

    . Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 2010;41:450–54 doi:10.1161/STROKEAHA.109.564914 pmid:20056930

    Abstract/FREE Full Text
35. 35.↵
    2. Roher AE,
    3. Kuo Y-M,
    4. Esh C, et al

    . Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 2003;9:112 doi:10.1007/BF03402043 pmid:12865947

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Cumurciuc R,
    3. Guichard JP,
    4. Reizine D, et al

    . Dilation of Virchow‐Robin spaces in CADASIL. Eur J Neurol 2006;13:187–90 doi:10.1111/j.1468-1331.2006.01113.x pmid:17515963

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Iliff JJ,
    3. Wang M,
    4. Liao Y, et al

    . A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 2012;4:147ra111 doi:10.1126/scitranslmed.3003748 pmid:22896675

    Abstract/FREE Full Text